Ticker League

SELLAS Life Sciences Group (SLS) Profit Bridge

See what drove SELLAS Life Sciences Group's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

TTM

Revenue YoY

Operating Income YoY

-12.65%

Net Income YoY

-8.60%

Net Margin Δ

Net income bridge for SELLAS Life Sciences Group (SLS) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: −$2.33M-8.60%

Profit bridge breakdown for SELLAS Life Sciences Group (SLS) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income−$27.13M
  • Revenue$0.00
  • Cost of Revenue$0.00
  • Operating Expenses−$3.53M
  • Other Income / Expense$1.20M
  • Income Tax$0.00
  • Net Loss−$29.46M
Identity check: drivers reconcile to ΔNI within $0.00
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation